Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Chem Pharm Bull (Tokyo) ; 68(8): 766-772, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32741918

RESUMO

Lactoferrin (Lf) nanoparticles have been developed as a carrier of drugs and gene. Two main methods, desolvation technique and emulsification method, for preparation of protein nanoparticles have been reported so far, but most of the previous reports of Lf nanoparticles preparation are limited to emulsification method. In this study, we investigated the optimal conditions by desolvation technique for the preparation of glutaraldehyde-crosslinked bovine Lf (bLf) nanoparticles within the size range of 100-200 nm, and evaluated their properties as a carrier for oral and intravenous drug delivery. The experimental results of dynamic light scattering and Transmission Electron Microscope suggested that glutaraldehyde-crosslinked bLf nanoparticles with 150 nm in size could be produced by addition of 2-propanol as the desolvating solvent into the bLf solution adjusted to pH 6, followed by crosslinking with glutaraldehyde. These cross-linked bLf nanoparticles were found to be compatible to blood components and resistant against rapid degradation by pepsin. Thus, cross-linked bLf nanoparticles prepared by desolvation technique can be applied as a drug carrier for intravenous administration and oral delivery.


Assuntos
Lactoferrina/química , Nanopartículas/química , 2-Propanol/química , Administração Oral , Animais , Materiais Biocompatíveis/química , Materiais Biocompatíveis/farmacologia , Bovinos , Portadores de Fármacos/química , Glutaral/química , Hemólise/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Lactoferrina/sangue , Nanopartículas/toxicidade , Tamanho da Partícula , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA